Starting August 1, 2024, Quickarrays, Inc. will be providing all products and services in place of Pantomics Inc.
SERVICES
CUSTOM TMA
ROUTINE PATHOLOGY
IHC / IMMUNOFLUORESCENCE
ISH / FISH
CONTRACTED SERVICES
PRIMARY IHC ANTIBODIES
PATHOLOGY FIELD
Hermatopathology
DETECTION SYSTEMS
ANCILLARIES
CONTROL TMA
LUC1503
Lung cancer tissue array, set 3, non-overlapping with LUC1501 or LUC1502, 150 cores from normal/benign (5 cases) and cancer (70 cases with grading and TNM staging data) tissues in duplicates.
Specification
Data Sheet
TNM Grading
Downloads
Price
Size
Availability
$307
1 slide
In-Stock
A | |
B | |
C | |
D | |
E | |
F | |
G | |
H | |
I | |
J | |















TNM Classification: Lung carcinoma
T- Primary tumor
TX - Primary tumor cannot be assessed or tumor proven by the presence of malignant cell in sputum or bronchial washing but not visualized by imaging of bronchoscopy;
TO - No evidence of primary tumor;
Tis- Carcinoma in situ;
T1 - Tumor 3 cm or less in greatest dimension, surrounded by lung or visceral pleura without bronchoscopic evidence of invasion more proximal than lobular bronchus;
T2 - Tumor with any of the following features of size or extent; more than 3 cm in greatest dimension; involves main bronchus, 2 cm more proximal to carina; invades visceral pleura; associated with atelectasis or obstructive pneumonitis that extends to the hilar region but not involve the entire lung;
T3 - Tumor of any size that directly invades any of the followings: chest wall (including superior sulcus tumor), diaphragm, mediastinal pleura, parietal pericardium; tumors in the main bronchus less than 3 cm distal to the carina; associated with atelectasis or obstructive pneumonitis of entire lung;
T4 - Tumor of any size that invades any of the following: mediastinum, heart, great vessel, trachea, esophagus, vertebral body, carina, separate tumor nodule(s) in the same,lobe; tumor with malignant pleural effusion.
N - Regional lymph nodes
NX - Regional lymph nodes cannot be assessed;
NO - No regional lymph node metastasis;
N1 - Metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary nodes, including involvement by direct extension;
N2 - Metastasis in ipsilateral mediastinal and/or subcarinal lymph nodes;
N3 - Metastasis in contralateral mediastinal, contralateral hilar, ipsilateral or contralateral, scalene, or supraclavicular lymph nodes.
M - Distant metastasis
MX - Distant metastasis cannot be assessed MO - No distant metastasis;
M1 - Distant metastasis, including separate tumor nodule(s) in a different lobe (ipsilateral or contralateral).
Human
75
150
1.1 mm
4um
10
15
Paraffin
Notes:
All tissues were fixed in 10% neutral buffered formalin for 24 hours and processed using identical SOPs. Sections were picked onto Superfrost Plus or Startfrost Adhesive slides. They all have a guaranteed six month shelf-life at 4C from the date of shipment. Additional cores not listed are orientation markers and have no data. There maybe <5% core loss per slide but the core retention rate should be >90%.
Bake at 60C for 30 minutes before use. If antigen retrieving is needed, it is always a good idea to start with a protocol with weak to mild strength. Please check our TNM guide as a reference. For IHC related information on products that provide them, please contact us at info@pantomics.com for the most up-to-date information.
For research use only. Designed for IHC or ISH based protein or RNA tissue profiling in lung cancers.

ARRAY POSITION | IMAGE | SEX | AGE | ANATOMIC SITE | PATHOLOGY | GRADE | STAGE (TNM) |
|---|---|---|---|---|---|---|---|
A01 | M | 50 | Lung | Normal | |||
A02 | F | 53 | Lung | Normal lung | |||
A03 | F | 48 | Lung | Pneumonia | |||
A04 | M | 52 | Lung | Chronic pneumonia | |||
A05 | F | 41 | Lung | Tuberculosis, TB granuloma | |||
A06 | F | 45 | Lung | Small cell carcinoma | T2N0M0 | ||
A07 | F | 52 | Lung | Papillary adenocarcinoma | T2N2M0 | ||
A08 | M | 50 | Lung | Squamous cell carcinoma | I~II | T2N0M0 | |
A09 | M | 54 | Lung | Squamous cell carcinoma | III | T2N0M0 | |
A10 | M | 45 | Lung | Small cell carcinoma | T2N1M0 | ||
A11 | M | 60 | Lung | Squamous cell carcinoma | II~III | T2N1M0 | |
A12 | M | 51 | Lung | Squamous cell carcinoma | III | T2N0M0 | |
A13 | M | 73 | Lung | Squamous cell carcinoma | II | T2N0M0 | |
A14 | M | 56 | Lung | Squamous cell carcinoma | I~II | T2N1M0 | |
A15 | F | 31 | Lung | Squamous cell carcinoma | III | T2N1M0 | |
B01 | M | 50 | Lung | Normal | |||
B02 | F | 53 | Lung | Normal lung | |||
B03 | F | 48 | Lung | Pneumonia | |||
B04 | M | 52 | Lung | Chronic pneumonia | |||
B05 | F | 41 | Lung | Tuberculosis, TB granuloma | |||
B06 | F | 45 | Lung | Small cell carcinoma | T2N0M0 | ||
B07 | F | 52 | Lung | Papillary adenocarcinoma | T2N2M0 | ||
B08 | M | 50 | Lung | Squamous cell carcinoma | I~II | T2N0M0 | |
B09 | M | 54 | Lung | Squamous cell carcinoma | III | T2N0M0 | |
B10 | M | 45 | Lung | Small cell carcinoma | T2N1M0 | ||
B11 | M | 60 | Lung | Squamous cell carcinoma | II~III | T2N1M0 | |
B12 | M | 51 | Lung | Squamous cell carcinoma | III | T2N0M0 | |
B13 | M | 73 | Lung | Squamous cell carcinoma | II | T2N0M0 | |
B14 | M | 56 | Lung | Squamous cell carcinoma | I~II | T2N1M0 | |
B15 | F | 31 | Lung | Squamous cell carcinoma | III | T2N1M0 | |
C01 | M | 49 | Lung | Undifferentiated carcinoma | T2N0M0 | ||
C02 | M | 59 | Lung | Papillary adenocarcinoma | T2N0M0 | ||
C03 | F | 65 | Lung | Papillary adenocarcinoma | T4N0M0 | ||
C04 | F | 59 | Lung | Adenocarcinoma | II | T2N1M0 | |
C05 | M | 70 | Lung | Squamous cell carcinoma | II~III | T3N1M0 | |
C06 | M | 47 | Lung | Bronchioloalveolar carcinoma | T2N0M0 | ||
C07 | M | 74 | Lung | Squamous cell carcinoma | II~III | T2N0M0 | |
C08 | M | 63 | Lung | Squamous cell carcinoma | II~III | T3N1M0 | |
C09 | M | 64 | Lung | Adenocarcinoma | II | T2N0M0 | |
C10 | M | 53 | Lung | Adenosquamous carcinoma | T2N1M0 | ||
C11 | M | 50 | Lung | Squamous cell carcinoma | III | T2N0M0 | |
C12 | M | 51 | Lung | Adenosquamous carcinoma | T3N1M0 | ||
C13 | M | 60 | Lung | Squamous cell carcinoma | II | T3N3M0 | |
C14 | M | 74 | Lung | Bronchioloalveolar carcinoma | T4N0M0 | ||
C15 | M | 74 | Lung | Bronchioloalveolar carcinoma | T3N0M0 | ||
D01 | M | 49 | Lung | Undifferentiated carcinoma | T2N0M0 | ||
D02 | M | 59 | Lung | Papillary adenocarcinoma | T2N0M0 | ||
D03 | F | 65 | Lung | Papillary adenocarcinoma | T4N0M0 | ||
D04 | F | 59 | Lung | Adenocarcinoma | II | T2N1M0 | |
D05 | M | 70 | Lung | Squamous cell carcinoma | II~III | T3N1M0 | |
D06 | M | 47 | Lung | Bronchioloalveolar carcinoma | T2N0M0 | ||
D07 | M | 74 | Lung | Squamous cell carcinoma | II~III | T2N0M0 | |
D08 | M | 63 | Lung | Squamous cell carcinoma | II~III | T3N1M0 | |
D09 | M | 64 | Lung | Adenocarcinoma | II | T2N0M0 | |
D10 | M | 53 | Lung | Adenosquamous carcinoma | T2N1M0 | ||
D11 | M | 50 | Lung | Squamous cell carcinoma | III | T2N0M0 | |
D12 | M | 51 | Lung | Adenosquamous carcinoma | T3N1M0 | ||
D13 | M | 60 | Lung | Squamous cell carcinoma | II | T3N3M0 | |
D14 | M | 74 | Lung | Bronchioloalveolar carcinoma | T4N0M0 | ||
D15 | M | 74 | Lung | Bronchioloalveolar carcinoma | T3N0M0 | ||
E01 | M | 69 | Lung | Squamous cell carcinoma | I | T3N0M0 | |
E02 | M | 40 | Lung | Squamous cell carcinoma | II~III | T3N1M0 | |
E03 | M | 68 | Lung | Squamous cell carcinoma | II~III | T2N0M0 | |
E04 | M | 56 | Lung | Adenocarcinoma | T3N1M0 | ||
E05 | F | 63 | Lung | Squamous cell carcinoma | III | T2N0M0 | |
E06 | F | 55 | Lung | Bronchioloalveolar carcinoma | T2N0M0 | ||
E07 | M | 42 | Lung | Bronchioloalveolar carcinoma | T2N0M0 | ||
E08 | F | 70 | Lung | Adenocarcinoma | II | T2N0M0 | |
E09 | M | 51 | Lung | Squamous cell carcinoma | III | T3N1M0 | |
E10 | M | 53 | Lung | Adenosquamous carcinoma | T2N0M0 | ||
E11 | F | 42 | Lung | Bronchioloalveolar carcinoma | T3N1M0 | ||
E12 | F | 45 | Lung | Adenocarcinoma | II~III | T2N0M0 | |
E13 | M | 53 | Lung | Undifferentiated carcinoma | T2N0M0 | ||
E14 | F | 44 | Lung | Adenocarcinoma | II | T2N0M0 | |
E15 | M | 78 | Lung | Squamous cell carcinoma | II~III | T2N1M0 | |
F01 | M | 69 | Lung | Squamous cell carcinoma | I | T3N0M0 | |
F02 | M | 40 | Lung | Squamous cell carcinoma | II~III | T3N1M0 | |
F03 | M | 68 | Lung | Squamous cell carcinoma | II~III | T2N0M0 | |
F04 | M | 56 | Lung | Adenocarcinoma | T3N1M0 | ||
F05 | F | 63 | Lung | Squamous cell carcinoma | III | T2N0M0 | |
F06 | F | 55 | Lung | Bronchioloalveolar carcinoma | T2N0M0 | ||
F07 | M | 42 | Lung | Bronchioloalveolar carcinoma | T2N0M0 | ||
F08 | F | 70 | Lung | Adenocarcinoma | II | T2N0M0 | |
F09 | M | 51 | Lung | Squamous cell carcinoma | III | T3N1M0 | |
F10 | M | 53 | Lung | Adenosquamous carcinoma | T2N0M0 | ||
F11 | F | 42 | Lung | Bronchioloalveolar carcinoma | T3N1M0 | ||
F12 | F | 45 | Lung | Adenocarcinoma | II~III | T2N0M0 | |
F13 | M | 53 | Lung | Undifferentiated carcinoma | T2N0M0 | ||
F14 | F | 44 | Lung | Adenocarcinoma | II | T2N0M0 | |
F15 | M | 78 | Lung | Squamous cell carcinoma | II~III | T2N1M0 | |
G01 | M | 72 | Lung | Adenosquamous carcinoma | T2N0M0 | ||
G02 | M | 70 | Lung | Adenocarcinoma | II~III | T2N0M0 | |
G03 | M | 53 | Lung | Squamous cell carcinoma | III | T2N1M0 | |
G04 | M | 67 | Lung | Squamous cell carcinoma | III | T2N1M0 | |
G05 | M | 44 | Lung | Adenocarcinoma | II | T2N0M0 | |
G06 | M | 61 | Lung | Adenocarcinoma | III | T2N1M0 | |
G07 | M | 59 | Lung | Squamous cell carcinoma | III | T2N1M0 | |
G08 | M | 51 | Lung | Squamous cell carcinoma | III | T2N0M0 | |
G09 | M | 43 | Lung | Squamous cell carcinoma | III | T2N1M0 | |
G10 | M | 54 | Lung | Squamous cell carcinoma | III | T3N0M0 | |
G11 | M | 47 | Lung | Bronchioloalveolar carcinoma | T2N0M0 | ||
G12 | M | 65 | Lung | Squamous cell carcinoma | II | T3N1M0 | |
G13 | M | 58 | Lung | Adenosquamous carcinoma | T2N0M0 | ||
G14 | M | 75 | Lung | Squamous cell carcinoma | II~III | T2N0M0 | |
G15 | M | 49 | Lung | Squamous cell carcinoma | II | T2N1M0 | |
H01 | M | 72 | Lung | Adenosquamous carcinoma | T2N0M0 | ||
H02 | M | 70 | Lung | Adenocarcinoma | II~III | T2N0M0 | |
H03 | M | 53 | Lung | Squamous cell carcinoma | III | T2N1M0 | |
H04 | M | 67 | Lung | Squamous cell carcinoma | III | T2N1M0 | |
H05 | M | 44 | Lung | Adenocarcinoma | II | T2N0M0 | |
H06 | M | 61 | Lung | Adenocarcinoma | III | T2N1M0 | |
H07 | M | 59 | Lung | Squamous cell carcinoma | III | T2N1M0 | |
H08 | M | 51 | Lung | Squamous cell carcinoma | III | T2N0M0 | |
H09 | M | 43 | Lung | Squamous cell carcinoma | III | T2N1M0 | |
H10 | M | 54 | Lung | Squamous cell carcinoma | III | T3N0M0 | |
H11 | M | 47 | Lung | Bronchioloalveolar carcinoma | T2N0M0 | ||
H12 | M | 65 | Lung | Squamous cell carcinoma | II | T3N1M0 | |
H13 | M | 58 | Lung | Adenosquamous carcinoma | T2N0M0 | ||
H14 | M | 75 | Lung | Squamous cell carcinoma | II~III | T2N0M0 | |
H15 | M | 49 | Lung | Squamous cell carcinoma | II | T2N1M0 | |
I01 | M | 59 | Lung | Squamous cell carcinoma | II | T2N0M0 | |
I02 | M | 63 | Lung | Squamous cell carcinoma | III | T2N1M0 | |
I03 | M | 52 | Lung | Squamous cell carcinoma | III | T2N1M0 | |
I04 | M | 63 | Lung | Squamous cell carcinoma | III | T2N0M0 | |
I05 | M | 60 | Lung | Squamous cell carcinoma | III | T2N1M0 | |
I06 | F | 58 | Lung | Bronchioloalveolar carcinoma | T2N0M0 | ||
I07 | M | 51 | Lung | Adenocarcinoma | III | T3N0M0 | |
I08 | M | 45 | Lung | Adenocarcinoma | I~II | T2N1M0 | |
I09 | M | 50 | Lung | Squamous cell carcinoma | II~III | T2N1M0 | |
I10 | M | 42 | Lung | Adenocarcinoma | II | T2N1M0 | |
I11 | M | 73 | Lung | Squamous cell carcinoma | II | T2N0M0 | |
I12 | M | 55 | Lung | Undifferentiated carcinoma | T2N0M0 | ||
I13 | M | 55 | Lung | Adenocarcinoma | III | T3N1M0 | |
I14 | F | 62 | Lung | Adenocarcinoma | II | T2N1M0 | |
I15 | M | 52 | Lung | Adenosquamous carcinoma | T2N0M0 | ||
J01 | M | 59 | Lung | Squamous cell carcinoma | II | T2N0M0 | |
J02 | M | 63 | Lung | Squamous cell carcinoma | III | T2N1M0 | |
J03 | M | 52 | Lung | Squamous cell carcinoma | III | T2N1M0 | |
J04 | M | 63 | Lung | Squamous cell carcinoma | III | T2N0M0 | |
J05 | M | 60 | Lung | Squamous cell carcinoma | III | T2N1M0 | |
J06 | F | 58 | Lung | Bronchioloalveolar carcinoma | T2N0M0 | ||
J07 | M | 51 | Lung | Adenocarcinoma | III | T3N0M0 | |
J08 | M | 45 | Lung | Adenocarcinoma | I~II | T2N1M0 | |
J09 | M | 50 | Lung | Squamous cell carcinoma | II~III | T2N1M0 | |
J10 | M | 42 | Lung | Adenocarcinoma | II | T2N1M0 | |
J11 | M | 73 | Lung | Squamous cell carcinoma | II | T2N0M0 | |
J12 | M | 55 | Lung | Undifferentiated carcinoma | T2N0M0 | ||
J13 | M | 55 | Lung | Adenocarcinoma | III | T3N1M0 | |
J14 | F | 62 | Lung | Adenocarcinoma | II | T2N1M0 | |
J15 | M | 52 | Lung | Adenosquamous carcinoma | T2N0M0 | ||
null |